Revealing a cancer-associated fibroblast-based risk signature for pancreatic adenocarcinoma through single-cell and bulk RNA-seq analysis
The prognosis of PAAD can be accurately predicted using the CAF-based risk signature, and a thorough analysis of the PAAD CAF signature may aid in deciphering the patient's immunotherapy response and presenting fresh cancer treatment options.
Authors
- Zhi‐Nan Chen (ORCID: https://orcid.org/0000-0001-5512-4623)
- Jing Ma
- Limin Hou (ORCID: https://orcid.org/0000-0003-2308-0501)
Institutions
- Harbin Medical University (CN)
- First Affiliated Hospital of Harbin Medical University (CN)
Publication Details
- Journal
- Aging
- Published
- 2024-09-26
- DOI
- https://doi.org/10.18632/aging.206043
- Citations
- 4
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 1.13